Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ocular perfusion pressure and visual field indice modifications induced by alpha-agonist compound (clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2%) topical administration. An acute study on primary open-angle glaucoma patients.
Costagliola C, Parmeggiani F, Ciancaglini M, D'Oronzo E, Mastropasqua L, Sebastiani A. Costagliola C, et al. Ophthalmologica. 2003 Jan-Feb;217(1):39-44. doi: 10.1159/000068249. Ophthalmologica. 2003. PMID: 12566871 Clinical Trial.
Hyperprolactinemia and lens opacities.
Costagliola C, Mastropasqua L, Amato G, Carella C. Costagliola C, et al. Ann Ophthalmol. 1992 Nov;24(11):418-9. Ann Ophthalmol. 1992. PMID: 1476397
Influence of lens opacities on visual field indices.
Costagliola C, De Simone C, Giacoia A, Iuliano G, Landolfo V. Costagliola C, et al. Ophthalmologica. 1990;201(4):180-6. doi: 10.1159/000310149. Ophthalmologica. 1990. PMID: 2077454
Effects of ketanserin on intraocular pressure.
Costagliola C, Fasano ML, Iuliano G, Ferrara LA. Costagliola C, et al. Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:97-9. doi: 10.1007/BF00053437. Cardiovasc Drugs Ther. 1990. PMID: 2285657 Clinical Trial.
358 results